A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

NCT02209766 ↗

Phase 1 Completed 86 enrolled AstraZeneca

Non-randomizedParallel-groupSingle-blindBasic science

Summary

The purpose of this study is to assess safety, tolerability and pharmacokinetics of D5884 following administration of single and multiple doses in healthy male Japanese subjects.

Timeline

Start: 2014-08
Primary completion: 2014-11
Completion: 2014-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	D5884	Unknown	2 g	Oral
Subject	D5884	Unknown	4 g	Oral

Indications

No indication recorded.